HPV vaccination after treatment for cervical dysplasia

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the potential protective role of HPV vaccination in women who have undergone treatment for HPV-related cervical lesions. Participants will be counseled about the benefits of vaccination and monitored for the risk of HPV recurrence. The study compares outcomes between those who choose to receive the vaccine and those who do not. It aims to gather data on the effectiveness of vaccination in preventing recurrence after excisional treatment.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Treatment of HPV-related disease

Exclusion Criteria:

* Previous HPV vaccination

Where it's running

• Fondazione IRCCS Istituto Nazionale dei Tumori
  Milan, Lombardy, Italy Recruiting
• Fondazione IRCCS Istituto Nazionale dei Tumori
  Milan, Lombardy, Italy Recruiting

Study contacts

• Principal investigator: Grazia Casadei, MD — Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
• Study coordinator: Giorgio Bogani, ph.d.
• Email: giorgiobogani@yahoo.it
• Phone: 651-296-9676

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Point-of-care triage and thermal treatment for cervical precancer with the IRIS device

  This project tests a portable thermal ablation device plus an AI image triage tool to treat and prioritize HPV-positive women aged 30–49 with cervical precancer in El Salvador.

  Recruiting Basic Health International, Inc. · San Salvador, San Salvador Department · NCT07461818

• HPV self-sampling to improve cervical screening for women in Zaporizhzhia during the war

  This project will test whether giving women aged 30–60 in Zaporizhzhia HPV self-sampling kits can keep cervical screening going when clinic access is disrupted by the war.

  Recruiting Karolinska Institutet · Zaporizhzhya · NCT07275333

• Validation of a low-cost cervical cancer screening test

  This study is testing a new, low-cost cervical cancer screening tool to see if it works as well as traditional methods for women in El Salvador.

  Recruiting DL Analytics · San Salvador · NCT06815939

• Using Fenofibrate to treat cervical cancer and dysplasia

  This study is testing if Fenofibrate, a cholesterol-lowering drug, can help treat cervical cancer and pre-cancerous changes by trying to improve how cells work and slow down tumor growth.

  Recruiting Phase 1 Case Comprehensive Cancer Center · Cleveland, Ohio · NCT06191133

• Predicting how well imiquimod treatment works for cervical lesions

  This study is testing if certain immune markers can help predict how well the treatment imiquimod works for people with high-grade cervical lesions.

  Recruiting at 14 sites Catharina Ziekenhuis Eindhoven · Breda and 14 other locations · NCT05405270

• Investigating HPV and skin cancer risks in organ transplant recipients

  This study is trying to see if organ transplant recipients have a higher risk of HPV infections and skin cancer compared to people with normal immune systems.

  Recruiting at 3 sites Bispebjerg Hospital · Copenhagen NV, Capital Region and 2 other locations · NCT05284877

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.